Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rayner

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Journal of Medical Microbiology|December 1, 1992
Use of ribosomal RNA gene restriction patterns to investigate two outbreaks of Campylobacter enteritis in Melbourne, AustraliaW Tee, B Mayall, C R Lucas, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patientsStephanie J Wallace, Jian Li, Craig R Rayner, et al.
Infectious Diseases and Therapy|August 20, 2021
Correction to: Early Treatment of COVID-19 Disease: A Missed OpportunityJamie I Forrest, Craig R Rayner, Jay J H Park, et al.
Infectious Diseases and Therapy|October 14, 2020
Early Treatment of COVID-19 Disease: A Missed OpportunityJamie I Forrest, Craig R Rayner, Jay J H Park, et al.
Journal of Clinical Pharmacology|June 6, 2008
Population pharmacokinetics of oseltamivir when coadministered with probenecidCraig R Rayner, Pascal Chanu, Ronald Gieschke, et al.
The Annals of Pharmacotherapy|August 31, 2006
Pharmacokinetics of oseltamivir in young and very elderly subjectsMasaichi Abe, James Smith, Akinori Urae, et al.
Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programmeCraig R Rayner, Alan Forrest, Alison K Meagher, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Population pharmacokinetics of linezolid in patients treated in a compassionate-use programAlison K Meagher, Alan Forrest, Craig R Rayner, et al.
Advances in Therapy|November 8, 2011
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experienceJames R Smith, Craig R Rayner, Barbara Donner, et al.
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19Michael G Dodds, Eileen B Doyle, Angela M Reiersen, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Journal of Medical Microbiology|December 1, 1992
Use of ribosomal RNA gene restriction patterns to investigate two outbreaks of Campylobacter enteritis in Melbourne, AustraliaW Tee, B Mayall, C R Lucas, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patientsStephanie J Wallace, Jian Li, Craig R Rayner, et al.
Infectious Diseases and Therapy|August 20, 2021
Correction to: Early Treatment of COVID-19 Disease: A Missed OpportunityJamie I Forrest, Craig R Rayner, Jay J H Park, et al.
Infectious Diseases and Therapy|October 14, 2020
Early Treatment of COVID-19 Disease: A Missed OpportunityJamie I Forrest, Craig R Rayner, Jay J H Park, et al.
Journal of Clinical Pharmacology|June 6, 2008
Population pharmacokinetics of oseltamivir when coadministered with probenecidCraig R Rayner, Pascal Chanu, Ronald Gieschke, et al.
The Annals of Pharmacotherapy|August 31, 2006
Pharmacokinetics of oseltamivir in young and very elderly subjectsMasaichi Abe, James Smith, Akinori Urae, et al.
Clinical Pharmacokinetics|December 17, 2003
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programmeCraig R Rayner, Alan Forrest, Alison K Meagher, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Population pharmacokinetics of linezolid in patients treated in a compassionate-use programAlison K Meagher, Alan Forrest, Craig R Rayner, et al.
Advances in Therapy|November 8, 2011
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experienceJames R Smith, Craig R Rayner, Barbara Donner, et al.
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19Michael G Dodds, Eileen B Doyle, Angela M Reiersen, et al.
Pageof 15